chr12-30631907-G-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_006390.4(IPO8):​c.3004C>T​(p.Arg1002Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,610,626 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1002Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

IPO8
NM_006390.4 missense

Scores

1
9
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.939

Publications

2 publications found
Variant links:
Genes affected
IPO8 (HGNC:9853): (importin 8) The importin-alpha/beta complex and the GTPase Ran mediate nuclear import of proteins with a classical nuclear localization signal. The protein encoded by this gene is a member of a class of approximately 20 potential Ran targets that share a sequence motif related to the Ran-binding site of importin-beta. This protein binds to the nuclear pore complex and, along with RanGTP and RANBP1, inhibits the GAP stimulation of the Ran GTPase. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
IPO8 Gene-Disease associations (from GenCC):
  • VISS syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000177 (27/152160) while in subpopulation AFR AF = 0.000579 (24/41426). AF 95% confidence interval is 0.000399. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IPO8NM_006390.4 linkc.3004C>T p.Arg1002Trp missense_variant Exon 24 of 25 ENST00000256079.9 NP_006381.2 O15397-1
IPO8NM_001190995.2 linkc.2389C>T p.Arg797Trp missense_variant Exon 20 of 21 NP_001177924.1 O15397-2
IPO8XM_017018691.3 linkc.2953C>T p.Arg985Trp missense_variant Exon 24 of 25 XP_016874180.1
IPO8XM_017018692.2 linkc.2818C>T p.Arg940Trp missense_variant Exon 23 of 24 XP_016874181.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IPO8ENST00000256079.9 linkc.3004C>T p.Arg1002Trp missense_variant Exon 24 of 25 1 NM_006390.4 ENSP00000256079.4 O15397-1
IPO8ENST00000544829.5 linkc.2389C>T p.Arg797Trp missense_variant Exon 20 of 21 2 ENSP00000444520.1 O15397-2
IPO8ENST00000535598.1 linkc.475C>T p.Arg159Trp missense_variant Exon 3 of 3 3 ENSP00000446232.1 H0YH64

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000360
AC:
9
AN:
249900
AF XY:
0.0000222
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000247
AC:
36
AN:
1458466
Hom.:
0
Cov.:
29
AF XY:
0.0000207
AC XY:
15
AN XY:
725664
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33400
American (AMR)
AF:
0.0000671
AC:
3
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26096
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39670
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52946
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4724
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1110610
Other (OTH)
AF:
0.0000996
AC:
6
AN:
60238
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152160
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.000579
AC:
24
AN:
41426
American (AMR)
AF:
0.000131
AC:
2
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000105
Hom.:
0
Bravo
AF:
0.000193
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jan 31, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3004C>T (p.R1002W) alteration is located in exon 24 (coding exon 24) of the IPO8 gene. This alteration results from a C to T substitution at nucleotide position 3004, causing the arginine (R) at amino acid position 1002 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
T;.
Eigen
Benign
0.040
Eigen_PC
Benign
-0.068
FATHMM_MKL
Benign
0.29
N
LIST_S2
Uncertain
0.95
D;D
M_CAP
Benign
0.055
D
MetaRNN
Uncertain
0.70
D;D
MetaSVM
Benign
-0.51
T
MutationAssessor
Uncertain
2.5
M;.
PhyloP100
0.94
PrimateAI
Uncertain
0.72
T
PROVEAN
Pathogenic
-5.0
D;D
REVEL
Uncertain
0.30
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
D;.
Vest4
0.71
MVP
0.63
MPC
0.68
ClinPred
0.87
D
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.45
gMVP
0.64
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151232989; hg19: chr12-30784841; COSMIC: COSV56244177; API